Kelnor™ 1/35 (28 Day Regimen)
(ethynodiol diacetate and ethinyl
estradiol tablets, USP)
[BARR LABORATORIES, INC.]
ADVERSE REACTIONS
BRIEF SUMMARY OF PATIENT WARNINGS
CLINICAL PHARMACOLOGY:
CONTRAINDICATIONS:
DESCRIPTION:
DETAILED PATIENT LABELING
DOSAGE AND ADMINISTRATION
HOW SUPPLIED
INDICATIONS AND USAGE:
Information for patient:
NON-CONTRACEPTIVE HEALTH BENEFITS:
Overdosage:
PRECAUTIONS
REFERENCES:
WARNINGS:
Zovia 1/35E-28
Zovia 1/50E-28
(Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP)
Revised: December 2003
Rx only
[WATSON LABORATORIES, INC.]
ADVERSE REACTIONS
CLINICAL PHARMACOLOGY
CONTRAINDICATIONS
DESCRIPTION
DETAILED PATIENT LABELING
DOSAGE AND ADMINISTRATION
HOW SUPPLIED
INDICATIONS AND USAGE
OVERDOSAGE
PRECAUTIONS
REFERENCES
SPL UNCLASSIFIED SECTION
WARNINGS
Kelnor™ 1/35 (28 Day Regimen)Kelnor™ 1/35 (28 Day Regimen)